3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Leukemia, Myeloid, Acute
15
Myelodysplastic Syndromes
10
Recurrence
7
Ovarian Neoplasms
7
Multiple Myeloma
7
Pancreatic Neoplasms
6
Lymphoma
6
Lymphoma, Non-Hodgkin
5
Lymphoma, B-Cell
5
Colorectal Neoplasms
5
Burkitt Lymphoma
5
Stomach Neoplasms
4
Lymphoma, Large B-Cell, Diffuse
4
Leukemia, Myelomonocytic, Chronic
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Hodgkin Disease
4
Hematologic Neoplasms
4
Sarcoma
3
Osteosarcoma
3
Lymphoma, Mantle-Cell
3
Lymphoma, Follicular
3
Leukemia, Biphenotypic, Acute
3
Leukemia, B-Cell
3
Leukemia
3
Colonic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Urogenital Neoplasms
2
Triple Negative Breast Neoplasms
2
Thymoma
2
Interventions
Specimen Handling
5
Biopsy
5
Magnetic Resonance Spectroscopy
4
Cyclophosphamide
3
sodium-iodide symporter
2
ruxolitinib
2
duvelisib
2
cemiplimab
2
X-Rays
2
Vincristine
2
Prednisone
2
Photons
2
Immunoglobulin G
2
Etoposide
2
Doxorubicin
2
Disulfides
2
prednylidene
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
deltacortene
1
carmustine, poliferprosan 20 drug combination
1
Stem Cell Transplantation
1
Standard of Care
1
Practice Guidelines as Topic
1
Peripheral Blood Stem Cell Transplantation
1
Oxaliplatin
1
Nivolumab
1
Melphalan
1
Leukapheresis
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell
×
fludarabine
×
30 days
×
Clear all
No trials found.